614P Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC)
| Autor: | Corbaux, P., You, B., Kepenekian, V., Bakrin, N., Gelot, A., Dayde, D., Sajous, C., Lamuraglia, M., Peron, J., Glehen, O., Freyer, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S825-S825 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|